Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
A decade from discovery to therapy: Lingo-1, the dark horse in neurological and psychiatric disorders.
Molecular mechanisms of estrogen for neuroprotection in spinal cord injury and traumatic brain injury.
Occurrence of CCSVI in patients with MS and its relationship with iron metabolism and varicose veins.
Ultra-high field MRI: looking through the 'macroscope'
Serum 25(OH) Vitamin D levels is not associated with disability in multiple sclerosis patients: A case-control study.
[Pulmonary lymphangioleiomyomatosis of unusual revelation during multiple sclerosis].
Protein 4.1R attenuates autoreactivity in experimental autoimmune encephalomyelitis by suppressing CD4(+) T cell activation.
Latency of multifocal Visual Evoked Potentials in non-optic neuritis eyes of multiple sclerosis patients associated with optic radiation lesions.
Use of an early disease-modifying drug adherence measure to predict future adherence in patients with multiple sclerosis.
Demyelinating Disease following Anti-TNFa Treatment: A Causal or Coincidental Association? Report of Four Cases and Review of the Literature.
Expression profiling of the ubiquitin conjugating enzyme UbcM2 in murine brain reveals modest age-dependent decreases in specific neurons.
MicroRNA let-7e is associated with the pathogenesis of experimental autoimmune encephalomyelitis.
Physical activity and pediatric multiple sclerosis: Developing a research agenda.
Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies.
[Oral treatments in multiple sclerosis].
Human endogenous retrovirus-K contributes to motor neuron disease.
Neuromyelitis Optica with NMO-IgG/Anti-AQP4 Antibody Positive: First Case Reported from Uttarakhand India.
Loss of astrocytic leptin signaling worsens experimental autoimmune encephalomyelitis.
Gelsolin decreases actin toxicity and inflammation in murine multiple sclerosis.
Cerebrospinal fluid oligoclonal bands are important in the diagnosis of multiple sclerosis, unreasonably downplayed by the McDonald criteria 2010: Yes.
Kinetic Characterization of Ebselen, Chelerythrine and Apomorphine as Glutaminase Inhibitors.
FTY720 inhibits tubulointerstitial inflammation in albumin overload-induced nephropathy of rats via the Sphk1 pathway.
Cerebrospinal fluid analysis in the context of CNS demyelinating diseases.
Falls in people with multiple sclerosis compared with falls in healthy controls.
Acute optic neuritis: a clinical paradigm for evaluation of neuroprotective and restorative strategies?
Pages
« first
‹ previous
…
513
514
515
516
517
518
519
520
521
…
next ›
last »